These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 1719549)

  • 1. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
    Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison in different tissue preparations of the in vitro pharmacological profile of RP 67580, a new non-peptide substance P antagonist.
    Carruette A; Moussaoui SM; Champion A; Cottez D; Goniot P; Garret C
    Neuropeptides; 1992 Dec; 23(4):245-50. PubMed ID: 1282222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [RP 67580, a potent and selective substance P non-peptide antagonist].
    Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
    C R Acad Sci III; 1992; 314(5):199-204. PubMed ID: 1376187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.
    Moussaoui SM; Montier F; Carruette A; Blanchard JC; Laduron PM; Garret C
    Br J Pharmacol; 1993 May; 109(1):259-64. PubMed ID: 7684305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
    Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
    Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
    Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
    J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.
    Beaujouan JC; Heuillet E; Petitet F; Saffroy M; Torrens Y; Glowinski J
    Br J Pharmacol; 1993 Mar; 108(3):793-800. PubMed ID: 7682138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of substance P and related peptides by RP 67580 and CP-96,345, at tachykinin NK1 receptor sites, in the rat urinary bladder.
    Montier F; Carruette A; Moussaoui S; Boccio D; Garret C
    Eur J Pharmacol; 1994 Jan; 251(1):9-14. PubMed ID: 7511108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888.
    Fujii T; Murai M; Morimoto H; Maeda Y; Yamaoka M; Hagiwara D; Miyake H; Ikari N; Matsuo M
    Br J Pharmacol; 1992 Nov; 107(3):785-9. PubMed ID: 1282073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity.
    Oleynek JJ; Sedlock DM; Barrow CJ; Appell KC; Casiano F; Haycock D; Ward SJ; Kaplita P; Gillum AM
    J Antibiot (Tokyo); 1994 Apr; 47(4):399-410. PubMed ID: 7515038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
    Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
    Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
    Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
    Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
    Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
    Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V
    Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
    Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
    Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
    Gitter BD; Bruns RF; Howbert JJ; Waters DC; Threlkeld PG; Cox LM; Nixon JA; Lobb KL; Mason NR; Stengel PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):737-44. PubMed ID: 7473161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
    Pradier L; Ménager J; Le Guern J; Bock MD; Heuillet E; Fardin V; Garret C; Doble A; Mayaux JF
    Mol Pharmacol; 1994 Feb; 45(2):287-93. PubMed ID: 7509440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.